background
data
regard
rate
acut
respiratori
ill
health
care
worker
experi
longterm
antivir
prophylaxi
spars
object
determin
efficaci
toler
oseltamivir
prophylaxi
versu
season
influenza
vaccin
prevent
influenza
among
health
care
worker
method
conduct
pilot
random
control
studi
influenza
season
tertiari
care
set
adult
health
care
worker
year
age
recruit
randomli
assign
ratio
receiv
either
oseltamivir
tamiflu
roch
mg
daili
prophylaxi
season
influenza
fluvir
vaccin
adult
enrol
receiv
vaccin
receiv
prophylaxi
incid
symptomat
laboratoryconfirm
influenza
similar
particip
vaccin
prophylaxi
arm
respect
p
particip
develop
acut
respiratori
ill
studi
period
report
work
schedul
work
day
state
work
despit
feel
miser
busi
stay
home
particip
initi
oseltamivir
prophylaxi
four
discontinu
owe
side
effect
median
durat
oseltamivir
prophylaxi
day
continu
week
conclus
extend
season
suboptim
vaccin
match
health
care
worker
receiv
antivir
prophylaxi
season
influenza
vaccin
develop
symptomat
laboratoryconfirm
influenza
longterm
antivir
prophylaxi
influenza
gener
well
toler
good
complianc
influenza
highli
communic
diseas
annual
infect
rate
unvaccin
healthi
adult
rang
annual
influenza
vaccin
offer
best
avail
protect
influenza
effect
limit
poor
uptak
among
popul
includ
health
care
worker
limit
abil
predict
influenza
evolut
match
vaccin
infect
strain
limit
efficaci
vaccin
vulner
popul
time
requir
produc
vaccin
event
pandem
antivir
also
shown
efficaci
prevent
influenza
experi
prolong
prophylact
use
limit
pilot
studi
intend
determin
rate
acut
respiratori
ill
work
adult
receiv
either
influenza
vaccin
antivir
prophylaxi
assess
proport
peopl
work
acut
respiratori
ill
also
describ
toler
adher
rate
influenza
infect
particip
receiv
antivir
prophylaxi
full
influenza
season
octob
adult
employe
student
age
year
respond
advertis
hospit
agre
particip
studi
exclud
origin
articl
particip
contraind
influenza
vaccin
oseltamivir
receiv
influenza
vaccin
immunoglobulin
within
month
studi
entri
expect
unabl
take
oral
oseltamivir
hour
plan
km
studi
site
consecut
week
studi
period
pregnant
breastfeed
plan
becom
pregnant
immunosuppress
condit
histori
cardiovascular
pulmonari
diseas
requir
prior
hospit
particip
anoth
trial
requir
administr
investig
medic
pilot
studi
approv
health
canada
research
ethic
board
mount
sinai
hospit
use
proc
ranuni
sa
sa
institut
cari
nc
usa
particip
randomli
assign
ratio
receiv
either
prophylaxi
oseltamivir
influenza
season
fluvir
vaccin
glaxosmithklin
inc
mississauga
ontario
canada
particip
investig
blind
enrol
vaccin
administ
particip
random
vaccin
arm
particip
random
antivir
group
contact
onset
influenza
season
definit
specimen
submit
ontario
provinci
public
health
laboratori
influenza
test
posit
two
consecut
week
prescrib
oseltamivir
mg
daili
end
influenza
season
protocol
definit
specimen
posit
two
consecut
week
studi
propos
call
particip
receiv
prophylaxi
maximum
week
howev
influenza
season
longer
anticip
signific
antigen
mismatch
circul
strain
influenza
vaccin
week
studi
particip
random
oseltamivir
given
option
continu
prophylaxi
discontinu
oseltamivir
vaccin
discontinu
prophylaxi
without
vaccin
studi
particip
random
vaccin
given
option
start
prophylaxi
questionnairebas
person
household
workrel
data
collect
enrol
particip
complet
weekli
diari
regard
symptom
contact
respiratori
ill
enrol
week
end
influenza
season
ill
diari
start
subject
either
fever
acut
onset
two
respiratori
symptom
runni
stuffi
nose
sneez
sore
scratchi
throat
hoars
cough
complet
daili
ill
resolv
particip
given
thermomet
ask
take
temperatur
felt
feverish
ask
nasopharyng
np
swab
taken
soon
possibl
onset
respiratori
symptom
acut
respiratori
ill
defin
acut
ill
last
hour
associ
either
fever
one
respiratori
symptom
two
respiratori
symptom
oseltamivir
adher
estim
selfreport
pill
count
visit
data
electron
medicin
vial
cap
record
date
time
time
cap
replac
nasopharyng
swab
test
ontario
public
health
laboratori
use
inhous
polymeras
chain
reaction
pcr
detect
influenza
viral
cultur
seeplex
multiplex
pcr
serum
collect
baselin
day
follow
vaccin
vaccin
group
begin
influenza
season
antivir
group
midseason
februari
end
influenza
season
hemagglutin
inhibit
hi
assay
conduct
nation
microbiolog
laboratori
winnipeg
manitoba
strain
influenza
includ
influenza
vaccin
solomon
island
wisconsin
b
malaysia
circul
strain
brisban
b
florida
influenza
infect
defin
fourfold
increas
hi
titr
sampl
preand
postvaccin
serum
sampl
obtain
particip
antivir
group
liver
enzym
test
perform
descript
statist
perform
differ
compar
use
wilcoxon
rank
sum
test
kruskalw
oneway
anova
continu
variabl
chisquar
fisher
exact
test
categor
variabl
level
signific
set
p
test
twotail
owe
small
number
exact
logist
regress
use
determin
associ
laboratoryconfirm
influenza
independ
variabl
statist
calcul
perform
use
stata
v
statacorp
colleg
station
tx
usa
enrol
women
men
median
age
year
rang
health
care
worker
vaccin
previou
year
fortyfour
particip
random
prophylaxi
vaccin
two
particip
prophylaxi
group
health
care
worker
drop
start
antivir
prophylaxi
includ
remain
analys
demograph
characterist
particip
particip
start
oseltamivir
prophylaxi
discontinu
week
owe
advers
effect
includ
nausea
week
nausea
malais
week
sleep
disturb
week
headach
week
thirtynin
particip
report
take
six
seven
capsul
per
week
first
week
week
report
continu
miss
one
capsul
per
week
week
six
particip
take
oseltamivir
elect
discontinu
prophylaxi
two
request
vaccin
one
peopl
vaccin
group
elect
start
oseltamivir
thu
particip
receiv
prophylaxi
week
week
particip
report
take
six
seven
capsul
per
week
week
continu
report
level
adher
studi
particip
took
oseltamivir
prophylaxi
day
median
took
median
capsul
per
personday
rang
averag
adher
report
take
medic
higher
within
first
week
latter
week
studi
versu
pill
per
personday
followup
p
exit
interview
selfrat
adher
prophylaxi
rang
median
signific
differ
selfreport
adher
adher
measur
pill
count
ecap
record
chang
serum
hepat
transaminas
document
particip
take
oseltamivir
seventi
respiratori
ill
episod
report
particip
zero
seven
ill
report
per
person
median
fiftytwo
np
swab
submit
particip
seven
yield
influenza
nine
yield
respiratori
virus
tabl
serolog
test
confirm
influenza
seven
particip
posit
np
swab
addit
five
particip
five
four
report
episod
acut
respiratori
ill
np
swab
submit
interv
two
blood
sampl
seroconvers
acut
respiratori
ill
rate
per
personday
influenza
infect
rate
per
personday
infect
rate
owe
respiratori
virus
ill
per
personday
median
symptom
durat
acut
respiratori
ill
day
rang
ill
durat
day
rang
case
laboratoryconfirm
influenza
n
day
rang
case
laboratoryconfirm
ill
owe
respiratori
virus
day
rang
report
ill
submit
np
swab
p
particip
report
work
regularli
schedul
work
day
acut
respiratori
ill
averag
particip
miss
day
work
per
ill
episod
cumul
total
work
day
per
personday
lost
owe
acut
respiratori
ill
day
work
acut
respiratori
ill
day
employe
report
feel
miser
busi
stay
home
associ
likelihood
work
ill
type
viru
detect
gender
age
averag
hour
work
per
week
profess
ten
ci
particip
oseltamivir
group
ci
particip
vaccin
group
p
infect
influenza
five
ten
influenza
infect
particip
oseltamivir
group
occur
prophylaxi
initi
tabl
demograph
clinic
factor
found
associ
infect
influenza
pilot
studi
rate
acut
respiratori
ill
influenza
season
similar
report
belgian
gener
practition
report
upper
respiratori
ill
period
two
winter
season
higher
report
two
recent
studi
use
postseason
health
care
worker
recal
infect
worker
report
symptom
upper
respiratori
infect
health
care
worker
recal
may
insensit
mean
identifi
acut
respiratori
infect
rel
busi
influenza
season
vaccin
circul
strain
mismatch
fact
studi
particip
health
care
worker
may
contribut
rel
high
influenza
attack
rate
cohort
infect
sever
particip
oseltamivir
arm
period
influenza
season
declar
emphas
signific
approxim
delay
canada
influenza
test
season
activ
report
fact
signific
number
case
influenza
occur
season
declar
year
rate
gastrointestin
upset
owe
oseltamivir
studi
similar
report
studi
case
report
within
day
start
oseltamivir
particip
report
rate
adher
prophylaxi
prolong
period
slightli
lower
report
studi
much
shorter
durat
prophylaxi
peopl
take
daili
dose
week
took
pill
poultri
worker
took
dose
cours
report
studi
particip
studi
report
work
great
major
schedul
work
day
acut
respiratori
ill
almost
third
work
despit
feel
miser
find
support
need
hospit
workplac
cultur
encourag
stay
home
ill
respiratori
ill
pilot
studi
power
elucid
differ
studi
arm
assess
risk
factor
ill
adher
prophylaxi
particip
primarili
healthi
adult
health
care
worker
will
accept
random
vaccin
antivir
prophylaxi
limit
generaliz
addit
relianc
selfpresent
collect
np
swab
led
underestim
ill
burden
owe
noninfluenza
respiratori
virus
influenza
vaccin
less
expens
conveni
antivir
prophylaxi
select
antivir
resist
nonetheless
studi
demonstr
vaccin
avail
eg
first
wave
pandem
contraind
prolong
oseltamivir
prophylaxi
may
feasibl
altern
